Search Results - "Peptide Fragments/therapeutic use"

Efficacy and Safety of Dapagliflozin in Heart Failure With Reduced Ejection Fraction According to N-Terminal Pro-B-Type Natriuretic Peptide: Insights From the DAPA-HF Trial.

Authors: Butt, Jawad H. Adamson, Carly Docherty, Kieran F. et al.

Source: Circulation Heart Failure. 14(12)

Subject Terms: Aged, Atrial Fibrillation/drug therapy/physiopathology, Benzhydryl Compounds/*adverse effects/*therapeutic use, clinical trials, Clinical Trials as Topic, Glucosides/*adverse effects/*therapeutic use, heart failure with reduced ejection fraction, Heart Failure/*drug therapy/physiopathology, Hospitalization/statistics & numerical data, Humans, Male, Middle Aged, Natriuretic Peptide, Brain/*therapeutic use, natriuretic peptides, Peptide Fragments/*therapeutic use, sodium-glucose cotransporter 2 inhibitors, Stroke Volume/drug effects, Ventricular Function, Left/drug effects

File Description: print

Access URL: https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-512644
https://doi.org/10.1161/CIRCHEARTFAILURE.121.008837

Stomach perforation-induced general occlusion/occlusion-like syndrome and stable gastric pentadecapeptide BPC 157 therapy effect

Authors: Kalogjera, Luka Krezić, Ivan Smoday, Ivan Maria et al.

Source: World J Gastroenterol

Subject Terms: Stomach Diseases, Stomach Diseases / drug therapy, Hemorrhage, Syndrome, Basic Study, Anti-Ulcer Agents, Peptide Fragments, Peptide Fragments / pharmacology, Rats, Anti-Ulcer Agents / therapeutic use, Peptide Fragments / therapeutic use, Stomach Diseases / etiology, Animals, Rats, Wistar

File Description: application/pdf

Access URL: https://pubmed.ncbi.nlm.nih.gov/37545637
https://urn.nsk.hr/urn:nbn:hr:105:649646
https://doi.org/10.3748/wjg.v29.i27.4289

Intranasal treatment with ovalbumin but not the major T cell epitope ovalbumin 323-339 generates interleukin-10 secreting T cells and results in the induction of allergen systemic tolerance

Authors: Barbey, C. Donatelli-Dufour, N. Batard, P. et al.

Subject Terms: Administration, Intranasal Adoptive Transfer Animals CD4-Positive T-Lymphocytes/immunology Cell Division/immunology Epitopes, T-Lymphocyte/therapeutic use Female Hypersensitivity/immunology/*prevention & control Immune Tolerance/*immunology Immunoglobulin E/biosynthesis Immunoglobulin G/biosynthesis Interleukin-10/*biosynthesis Lymphocyte Activation/immunology Lymphoid Tissue/immunology Mice Mice, Inbred BALB C Ovalbumin/immunology/*therapeutic use Peptide Fragments/therapeutic use T-Lymphocyte Subsets/*immunology

Relation: Clinical & Experimental Allergy; https://iris.unil.ch/handle/iris/81474; serval:BIB_04B00977F039; 000220857000025

Availability: https://iris.unil.ch/handle/iris/81474
https://doi.org/10.1111/j.1365-2222.2004.1929.x

Relation of cardiac troponin I measurements at 24 and 48 hours to magnetic resonance-determined infarct size in patients with ST-elevation myocardial infarction.

Authors: Hallén, J. Buser, P. Schwitter, J. et al.

Subject Terms: Aged, Angioplasty, Balloon, Coronary, Austria, Biological Markers/blood, Electrocardiography, Female, Fibrin Fibrinogen Degradation Products/therapeutic use, Heart Conduction System/physiopathology, Humans, Magnetic Resonance Imaging, Male, Middle Aged, Minnesota, Models, Statistical, Myocardial Infarction/blood, Myocardial Infarction/diagnosis, Myocardial Reperfusion Injury/prevention & control, Norway, Peptide Fragments/therapeutic use, Predictive Value of Tests, Prognosis, Randomized Controlled Trials as Topic, Regression Analysis, Research Design, Risk Factors, Sensitivity and Specificity, Switzerland

Relation: American journal of cardiology; https://iris.unil.ch/handle/iris/49105; serval:BIB_3C6C024EE79B; 000272637500003

Availability: https://iris.unil.ch/handle/iris/49105
https://doi.org/10.1016/j.amjcard.2009.07.019

Morphological Reconstitution and Persistent Changes After Intravitreal Ocriplasmin for Vitreomacular Traction and Macular Hole.

Authors: Zandi, S. Freiberg, F. Vaclavik, V. et al.

Subject Terms: Aged, 80 and over, Female, Fibrinolysin/administration & dosage, Fibrinolysin/therapeutic use, Fibrinolytic Agents/administration & dosage, Fibrinolytic Agents/therapeutic use, Humans, Intravitreal Injections, Male, Middle Aged, Peptide Fragments/administration & dosage, Peptide Fragments/therapeutic use, Retinal Perforations/drug therapy, Retinal Perforations/surgery, Traction, Vitrectomy, Jetrea, VMT, deposits, macular hole, ocriplasmin, vitreomacular traction

Relation: Journal of Ocular Pharmacology and Therapeutics; https://iris.unil.ch/handle/iris/266552; serval:BIB_9259BDEB268E; 000507502400001

Availability: https://iris.unil.ch/handle/iris/266552
https://doi.org/10.1089/jop.2019.0051

Bivalirudin use in acute coronary syndrome patients undergoing percutaneous coronary interventions in Poland: Clinical update from expert group of the Association on Cardiovascular Interventions of the Polish Cardiac Society

Authors: Wiktor Kuliczkowki Łukasz Kołtowski Dariusz Ciećwierz et al.

Source: Cardiol J

Subject Terms: Antithrombins - therapeutic use, Percutaneous coronary intervention - methods, Cardiology, Recombinant proteins - therapeutic use, Peptide fragments - therapeutic use, Hirudins, medical, Antithrombins, Peptide Fragments, Recombinant Proteins, 03 medical and health sciences, Percutaneous Coronary Intervention, Treatment Outcome, 0302 clinical medicine, Humans, Position Paper, Poland, Treatment outcome, Acute Coronary Syndrome, Societies, Acute coronary syndrome - drug therapy, Acute coronary syndrome - surgery, Societies, Medical

Access URL: https://journals.viamedica.pl/cardiology_journal/article/download/CJ.2019.0029/47831
https://pubmed.ncbi.nlm.nih.gov/30882184
https://pubmed.ncbi.nlm.nih.gov/30882184/
https://www.ncbi.nlm.nih.gov/pubmed/30882184
https://europepmc.org/article/MED/30882184
https://journals.viamedica.pl/cardiology_journal/article/download/CJ.2019.0029/47831
https://journals.viamedica.pl/cardiology_journal/article/view/63488
https://journals.viamedica.pl/cardiology_journal/article/view/63488
https://doi.org/10.5603/CJ.2019.0029
https://journals.viamedica.pl/cardiology_journal/article/download/CJ.2019.0029/47831
https://doi.org/10.5603/CJ.2019.0029

The effect of casein glycomacropeptide versus free synthetic amino acids for early treatment of phenylketonuria in a mice model

Authors: Ahring, Kirsten K. Dagnæs-Hansen, Frederik Brüel, Annemarie et al.

Source: Ahring, K K, Dagnæs-Hansen, F, Brüel, A, Christensen, M, Jensen, E, Jensen, T G, Johannsen, M, Johansen, K S, Lund, A M, Madsen, J G, Brøndum-Nielsen, K, Pedersen, M, Sørensen, L K, Kjolby, M & Møller, L B 2022, 'The effect of casein glycomacropeptide versus free synthetic amino acids for early treatment of phenylketonuria in a mice model', PLOS ONE, vol. 17, no. 1, e0261150. https://doi.org/10.1371/journal.pone.0261150

Subject Terms: Amino Acids/blood, Animals, Bone Density, Bone and Bones/diagnostic imaging, Brain/metabolism, Caseins/therapeutic use, Dietary Supplements, Disease Models, Animal, Female, Maze Learning, Mice, Inbred C57BL, Peptide Fragments/therapeutic use, Phenylalanine Hydroxylase/deficiency, Phenylalanine/analysis, Phenylketonurias/diet therapy, Serotonin/blood, Tyrosine/blood

Availability: https://pure.au.dk/portal/en/publications/e3729999-5996-45fb-b7e6-58ac73919dab
https://doi.org/10.1371/journal.pone.0261150
http://www.scopus.com/inward/record.url?scp=85122635820&partnerID=8YFLogxK

Counteraction of perforated cecum lesions in rats: effects of pentadecapeptide BPC 157, L-NAME and L-arginine

Authors: Drmić, Domagoj Samara, Mariam Vidović, Tinka et al.

Source: World J Gastroenterol

Subject Terms: Male, 0301 basic medicine, vessels, BPC 157, L-NAME, L-arginine, perforated cecum, rats, Drug Therapy, Combination/methods, Arginine, Nitric Oxide, Cecum/blood supply, 03 medical and health sciences, NG-Nitroarginine Methyl Ester/therapeutic use, Animals, Humans, NG-Nitroarginine Methyl Ester/pharmacology, Cecum/injuries, Rats, Wistar, Wound Healing/drug effects, Cecum, Intestinal Perforation/drug therapy, Peptide Fragments/therapeutic use, Wound Healing, 0303 health sciences, Peptide Fragments/pharmacology, Cecum/drug effects, Proteins, Basic Study, Proteins/pharmacology, Anti-Ulcer Agents, Peptide Fragments, Arginine/therapeutic use, Rats, 3. Good health, Disease Models, Animal, NG-Nitroarginine Methyl Ester, Treatment Outcome, Proteins/therapeutic use, Intestinal Perforation, Nitric Oxide/metabolism, Anti-Ulcer Agents/pharmacology, Drug Therapy, Combination, Anti-Ulcer Agents/therapeutic use, Arginine/pharmacology

File Description: application/pdf

Access URL: https://pubmed.ncbi.nlm.nih.gov/30622376
https://www.bib.irb.hr/981043
https://doi.org/10.3748/wjg.v24.i48.5462
https://www.wjgnet.com/1007-9327/full/v24/i48/5462.htm
https://doi.org/10.3748/wjg.v24.i48.5462
https://europepmc.org/article/MED/30622376
https://pubmed.ncbi.nlm.nih.gov/30622376/
https://www.ncbi.nlm.nih.gov/pubmed/30622376
https://www.wjgnet.com/1007-9327/full/v24/i48/5462.htm

Bypassing major venous occlusion and duodenal lesions in rats, and therapy with the stable gastric pentadecapeptide BPC 157, L-NAME and L-arginine

Authors: Amić, Fedor Drmić, Domagoj Bilić, Zdenko et al.

Source: World J Gastroenterol

Subject Terms: Male, 0301 basic medicine, L-arginine, duodenal lesions, BPC 157, bypassing, Random Allocation, Protective Agents/pharmacology, NG-Nitroarginine Methyl Ester/therapeutic use, major venous occlusion, Duodenum/drug effects, Venous Thrombosis, 2. Zero hunger, 0303 health sciences, Veins/drug effects, Colitis, Ischemic/etiology, Basic Study, Proteins/pharmacology, Arginine/therapeutic use, 3. Good health, Collateral Circulation/drug effects, NG-Nitroarginine Methyl Ester, Treatment Outcome, Protective Agents/therapeutic use, Venous Thrombosis/complications, reduction of free radical formation, Colitis, Ischemic, Duodenum, Duodenum/blood supply, Oxidative Stress/drug effects, Collateral Circulation, Arginine, Nitric Oxide, Protective Agents, Veins, Colitis, Ischemic/drug therapy, 03 medical and health sciences, L-NAME, Animals, Humans, NG-Nitroarginine Methyl Ester/pharmacology, Rats, Wistar, rats, Peptide Fragments/therapeutic use, Peptide Fragments/pharmacology, Duodenum/pathology, Proteins, Peptide Fragments, Rats, Disease Models, Animal, Oxidative Stress, Proteins/therapeutic use, Nitric Oxide/metabolism, Arginine/pharmacology

File Description: application/pdf

Access URL: https://pubmed.ncbi.nlm.nih.gov/30598581
https://pubmed.ncbi.nlm.nih.gov/30598581/
https://www.bib.irb.hr/978854
https://bib.irb.hr/datoteka/978854.WJG-24-5366.pdf
https://www.ncbi.nlm.nih.gov/pubmed/30598581
https://www.bib.irb.hr/978854/download/978854.WJG-24-5366.pdf
https://www.wjgnet.com/1007-9327/full/v24/i47/5366.htm

Relation of Bleeding Events to Mortality in Patients With ST-Segment Elevation Myocardial Infarction Treated by Percutaneous Coronary Intervention (a DANAMI-3 Substudy)

Authors: Sadjadieh, Golnaz Engstrøm, Thomas Helqvist, Steffen et al.

Source: Sadjadieh, G, Engstrøm, T, Helqvist, S, Høfsten, D E, Køber, L, Pedersen, F, Laursen, P N, Nepper-Christensen, L, Clemmensen, P, Møller-Helgestad, O K, Sørensen, R, Ravkilde, J, Terkelsen, C J, Jørgensen, E, Saunamäki, K, Tilsted, H-H, Kelbæk, H & Holmvang, L 2018, 'Relation of Bleeding Events to Mortality in Patients With ST-Segment Elevation Myocardial Infarction Treated by Percutaneous Coronary Intervention (a DANAMI-3 Substudy)', The American Journal of Cardiology, vol. 121, no. 7, pp. 781-788. https://doi.org/10.1016/j.amjcard.2017.12.019
Sadjadieh, G, Engstrøm, T, Helqvist, S, Høfsten, D E, Køber, L, Pedersen, F, Laursen, P N, Nepper-Christensen, L, Clemmensen, P, Møller-Helgestad, O K, Sørensen, R, Ravkilde, J, Terkelsen, C J, Jørgensen, E, Saunamäki, K, Tilsted, H H, Kelbæk, H & Holmvang, L 2018, ' Relation of Bleeding Events to Mortality in Patients With ST-Segment Elevation Myocardial Infarction Treated by Percutaneous Coronary Intervention (a DANAMI-3 Substudy) ', American Journal of Cardiology, vol. 121, no. 7, pp. 781-788 . https://doi.org/10.1016/j.amjcard.2017.12.019

Subject Terms: Male, Platelet Glycoprotein GPIIb-IIIa Complex/antagonists & inhibitors, Platelet Aggregation Inhibitors/therapeutic use, Platelet Glycoprotein GPIIb-IIIa Complex, Purinergic P2Y Receptor Antagonists/therapeutic use, Time-to-Treatment/statistics & numerical data, Postoperative Hemorrhage, Antithrombins, 03 medical and health sciences, Sex Factors, Percutaneous Coronary Intervention, 0302 clinical medicine, Recombinant Proteins/therapeutic use, Journal Article, 80 and over, ST Elevation Myocardial Infarction/surgery, Humans, Antithrombins/therapeutic use, Mortality, Heparin/therapeutic use, Proportional Hazards Models, Aged, Aged, 80 and over, Peptide Fragments/therapeutic use, Postoperative Hemorrhage/epidemiology, Aspirin, Heparin, Incidence, Anticoagulants, Creatinine/blood, Hirudins, Middle Aged, Prognosis, Peptide Fragments, 3. Good health, Anticoagulants/therapeutic use, Creatinine, Aspirin/therapeutic use, Multivariate Analysis, Female, Platelet Aggregation Inhibitors

Access URL: https://pubmed.ncbi.nlm.nih.gov/29402421
http://findresearcher.sdu.dk/portal/da/publications/relation-of-bleeding-events-to-mortality-in-patients-with-stsegment-elevation-myocardial-infarction-treated-by-percutaneous-coronary-intervention-a-danami3-substudy(a22752ae-fe8c-4262-b152-b8151e731243).html
https://www.sciencedirect.com/science/article/pii/S0002914918300390
https://fis-uhz.de/portal/de/publications/relation-of-bleeding-events-to-mortality-in-patients-with-stsegment-elevation-myocardial-infarction-treated-by-percutaneous-coronary-intervention-a-danami3-substudy(369b6553-3e82-4bed-90e0-d2cb3c5a1dc4).html
https://www.ncbi.nlm.nih.gov/pubmed/29402421
http://europepmc.org/abstract/MED/29402421
https://pubmed.ncbi.nlm.nih.gov/29402421/
https://portal.findresearcher.sdu.dk/da/publications/a22752ae-fe8c-4262-b152-b8151e731243

Fibrin-derived peptide Bβ15-42 (FX06) as salvage treatment in critically ill patients with COVID-19-associated acute respiratory distress syndrome

Authors: Elisabeth H. Adam Benedikt Schmid Michael Sonntagbauer et al.

Source: Crit Care
Critical Care, Vol 24, Iss 1, Pp 1-4 (2020)

Subject Terms: Immunomodulatory agents, Male, Critical Illness, Pneumonia, Viral, Comorbidity, Therapies, investigational, Fibrin Fibrinogen Degradation Products, Betacoronavirus, 03 medical and health sciences, 0302 clinical medicine, Pulmonary edema, Research Letter, Humans, Pandemics, Aged, Salvage Therapy, ddc:610, Respiratory distress syndrome, adult, Respiratory Distress Syndrome, RC86-88.9, SARS-CoV-2, COVID-19, Medical emergencies. Critical care. Intensive care. First aid, Middle Aged, Critical care, Pneumonia, Viral/therapy [MeSH], Aged [MeSH], Coronavirus Infections/therapy [MeSH], Fibrin Fibrinogen Degradation Products/therapeutic use [MeSH], Respiratory Distress Syndrome/virology [MeSH], Critical Illness/therapy [MeSH], Male [MeSH], COVID-19 [MeSH], Comorbidity [MeSH], SARS-CoV-2 [MeSH], Female [MeSH], Humans [MeSH], Salvage Therapy [MeSH], Middle Aged [MeSH], Pandemics [MeSH], Peptide Fragments/therapeutic use [MeSH], Respiratory Distress Syndrome/therapy [MeSH], Betacoronavirus [MeSH], Peptide Fragments, 3. Good health, Female, Coronavirus Infections

File Description: application/pdf

Access URL: https://ccforum.biomedcentral.com/track/pdf/10.1186/s13054-020-03293-8
https://pubmed.ncbi.nlm.nih.gov/32972429
https://doaj.org/article/953e989e67c74769b235ce902413a125
https://ccforum.biomedcentral.com/articles/10.1186/s13054-020-03293-8
https://europepmc.org/article/MED/32972429
https://pubmed.ncbi.nlm.nih.gov/32972429/
https://link.springer.com/content/pdf/10.1186/s13054-020-03293-8.pdf
https://www.ncbi.nlm.nih.gov/pubmed/32972429
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7512215
https://repository.publisso.de/resource/frl:6463097

Stable gastric pentadecapeptide BPC 157 in the treatment of colitis and ischemia and reperfusion in rats: New insights

Authors: Duzel, Antonija Vlainić, Josipa Antunović, Marko et al.

Source: World J Gastroenterol

Subject Terms: Male, 0301 basic medicine, L-arginine, blood flow rescue, BPC 157, Malondialdehyde, Colon/blood supply, NG-Nitroarginine Methyl Ester/therapeutic use, Colon/drug effects, oxidative stress, Nitric Oxide/analysis, Colitis/pathology, 0303 health sciences, Collaterals, Blood flow rescue, Basic Study, Proteins/pharmacology, Colitis, Colon/metabolism, Arginine/therapeutic use, 3. Good health, Collateral Circulation/drug effects, NG-Nitroarginine Methyl Ester, Reperfusion Injury, Reperfusion Injury/pathology, Anti-Ulcer Agents/therapeutic use, Colon, Oxidative Stress/drug effects, Collateral Circulation, ischemic colitis, Arginine, Nitric Oxide, NO, 03 medical and health sciences, L-NAME, Animals, Humans, Colitis/etiology, Reperfusion Injury/etiology, Malondialdehyde/blood, Rats, Wistar, Peptide Fragments/therapeutic use, Ischemic colitis, Oxidative stress, Rats, Peptide Fragments/pharmacology, collaterals, Proteins, Colitis/drug therapy, Anti-Ulcer Agents, Peptide Fragments, rats, Disease Models, Animal, Oxidative Stress, Proteins/therapeutic use, Reperfusion Injury/drug therapy, Anti-Ulcer Agents/pharmacology, Colitis/blood, Reperfusion Injury/blood

File Description: application/pdf

Access URL: https://pubmed.ncbi.nlm.nih.gov/29358856
https://www.ncbi.nlm.nih.gov/pubmed/29358856
https://doi.org/10.3748/wjg.v23.i48.8465
https://europepmc.org/article/MED/29358856
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5752708
https://www.ncbi.nlm.nih.gov/pubmed/29358856
https://www.bib.irb.hr/981047
https://www.wjgnet.com/1007-9327/full/v23/i48/8465.htm
http://doi.org/10.3748/wjg.v23.i48.8465

Thermo-sensitive assembly of the biomaterial REP reduces hematoma volume following collagenase-induced intracerebral hemorrhage in rats

Authors: Park, Joohyun Kim, Jong Youl Choi, Seong-Kyoon et al.

Contributors: Park, Joohyun Kim, Jong Youl Choi, Seong-Kyoon et al.

Source: Nanomedicine: Nanotechnology, Biology and Medicine. 13:1853-1862

Subject Terms: Male, 0301 basic medicine, VON-WILLEBRAND-FACTOR, PERINATAL BRAIN-INJURY, Cerebral Hemorrhage/drug therapy, Biocompatible Materials, HYPERTHERMIA, MICROGLIA, Rats, Sprague-Dawley, DELIVERY, 03 medical and health sciences, 0302 clinical medicine, INFLAMMATION, Animal, Tropoelastin, RGD-containing elastin-like polypeptide, Animals, Collagenases, Peptide Fragments/therapeutic use, IN-VIVO, Cerebral Hemorrhage, Hematoma/pathology, Tropoelastin/administration & dosage, Hematoma, Hematoma/therapy, Temperature, Neuroprotective Agents/therapeutic use, Nanomaterial, Peptide Fragments, Rats, 3. Good health, Tropoelastin/chemistry, Disease Models, Animal, Neuroprotective Agents, RESOLUTION, Disease Models, Thermodynamics, Hematoma/chemically induced, Sprague-Dawley, Microglia, Elastin-like polypeptide, Intracerebral hemorrhage, STEM-CELLS

File Description: application/pdf

Access URL: https://pubmed.ncbi.nlm.nih.gov/28412143
https://www.sciencedirect.com/science/article/abs/pii/S1549963417300618
https://pr.ibs.re.kr/handle/8788114/4053
https://yonsei.pure.elsevier.com/en/publications/thermo-sensitive-assembly-of-the-biomaterial-rep-reduces-hematoma
https://ir.ymlib.yonsei.ac.kr/bitstream/22282913/160459/1/T201702400.pdf
https://europepmc.org/abstract/MED/28412143
https://pubmed.ncbi.nlm.nih.gov/28412143/

Kisspeptin as a promising oocyte maturation trigger for in vitro fertilisation in humans

Authors: Kasum, Miro Franulić, Daniela Čehić, Ermin et al.

Source: Gynecological Endocrinology. 33:583-587

Subject Terms: Peptide Fragments/metabolism, Adult, Ovulation, Risk, Infertility, Female/therapy, Pregnancy Rate, Oogenesis/drug effects, Fertilization in Vitro, Ovarian Hyperstimulation Syndrome/chemically induced, Ovarian Hyperstimulation Syndrome, 03 medical and health sciences, Oogenesis, 0302 clinical medicine, Fertility Agents, Female/therapeutic use, Ovulation Induction, Pregnancy, Recombinant Proteins/therapeutic use, Fertility Agents, Female/adverse effects, Recombinant Proteins/adverse effects, Animals, Humans, Ovarian Hyperstimulation Syndrome/prevention & control, Fertilization in Vitro/adverse effects, Peptide Fragments/genetics, Kisspeptins/adverse effects, Recombinant Proteins/metabolism, Peptide Fragments/therapeutic use, Kisspeptins, Kisspeptins/therapeutic use, Peptide Fragments/adverse effects, Fertility Agents, Female, Peptide Fragments, Recombinant Proteins, 3. Good health, Ovulation/drug effects, Ovarian Hyperstimulation Syndrome/epidemiology, Ovulation Induction/adverse effects, Fertility Agents, Female/metabolism, Female, Kisspeptins/genetics, Infertility, Female, Kisspeptins/metabolism

File Description: application/pdf

Access URL: https://pubmed.ncbi.nlm.nih.gov/28393578
https://www.bib.irb.hr/965016
https://pubmed.ncbi.nlm.nih.gov/28393578/
https://www.tandfonline.com/doi/full/10.1080/09513590.2017.1309019
https://europepmc.org/abstract/MED/28393578
https://www.ncbi.nlm.nih.gov/pubmed/28393578
https://urn.nsk.hr/urn:nbn:hr:105:165983
https://doi.org/10.1080/09513590.2017.1309019

Neuroprotective effects of neurokinin receptor one in dopaminergic neurons are mediated through Akt/PKB cell signaling pathway

Authors: Chen, LW Yung, KKL Chan, YS et al.

Source: Neuropharmacology. 61:1389-1398

Subject Terms: Male, 0301 basic medicine, Dopamine Agonists - Pharmacology, Time Factors, Apomorphine, Neuroblastoma - Pathology, Gene Expression Regulation - Drug Effects, Rats, Sprague-Dawley, Neuroblastoma, Neurokinin-1 Receptor Antagonists, Pyrrolidonecarboxylic Acid - Analogs & Derivatives - Therapeutic Use, Receptors, Drug Interactions, Peptide Fragments - Therapeutic Use, Enzyme Inhibitors, Oxidopamine - Toxicity, 0303 health sciences, Tumor, Cell Death, Caspase 3, Tyrosine 3-Monooxygenase - Metabolism, 3. Good health, Neuroprotective Agents, L-Lactate Dehydrogenase - Metabolism, Dopamine Agonists, Drug, Neurokinin-1 - Agonists - Antagonists & Inhibitors - Metabolism, Cell Death - Drug Effects, Corpus Striatum - Drug Effects - Pathology, Dopaminergic Neurons - Drug Effects - Physiology, Enzyme Inhibitors - Pharmacology, Caspase 3 - Metabolism, Bcl-Associated Death Protein - Metabolism, Motor Activity, Sympatholytics - Toxicity, Cell Line, Neuroprotective Agents - Therapeutic Use, Dose-Response Relationship, 03 medical and health sciences, Cell Line, Tumor, Analysis Of Variance, Animals, Apomorphine - Pharmacology, Neurotoxicity Syndromes - Etiology - Pathology - Physiopathology - Prevention & Control, Analysis of Variance, Dose-Response Relationship, Drug, L-Lactate Dehydrogenase, Animal, Substance P - Analogs & Derivatives - Therapeutic Use, Dopaminergic Neurons, Signal Transduction - Drug Effects - Physiology, Receptors, Neurokinin-1 - Agonists - Antagonists & Inhibitors - Metabolism, Corpus Striatum, Proto-Oncogene Proteins C-Akt - Metabolism, Rats, Disease Models, Animal, Gene Expression Regulation, Rotarod Performance Test, Disease Models, Sprague-Dawley

Access URL: https://pubmed.ncbi.nlm.nih.gov/21907219
https://pubmed.ncbi.nlm.nih.gov/21907219/
http://hub.hku.hk/handle/10722/171786
https://core.ac.uk/display/37999291
https://www.ncbi.nlm.nih.gov/pubmed/21907219
https://scholars.hkbu.edu.hk/en/publications/neuroprotective-effects-of-neurokinin-receptor-one-in-dopaminergi-2
http://www.sciencedirect.com/science/article/pii/S0028390811003601
http://hdl.handle.net/10722/171786

Baseline Susceptibility of Primary HIV-2 to Entry Inhibitors

Authors: Borrego, Pedro Calado, Rita Marcelino, José M. et al.

Contributors: Borrego, Pedro Calado, Rita Marcelino, José M. et al.

Source: Antiviral Therapy. 17:565-570

Subject Terms: Male, 0301 basic medicine, Cyclohexanes/pharmacology, Amides/therapeutic use, Anti-HIV Agents, HIV Fusion Inhibitors/pharmacology, HCC INF, HIV Infections/drug therapy, HIV Infections, Microbial Sensitivity Tests, Cyclohexanes/therapeutic use, Enfuvirtide, HIV Envelope Protein gp41/therapeutic use, Maraviroc, Inhibitory Concentration 50, 03 medical and health sciences, Cyclohexanes, HIV Fusion Inhibitors, HSJ MED, Anti-HIV Agents/pharmacology, inhibitors, Humans, Amides/pharmacology, Peptide Fragments/therapeutic use, Quaternary Ammonium Compounds/therapeutic use, 0303 health sciences, Peptide Fragments/pharmacology, Triazoles/pharmacology, Quaternary Ammonium Compounds/pharmacology, HIV Fusion Inhibitors/therapeutic use, HIV Envelope Protein gp41/pharmacology, Triazoles, Amides, HIV Envelope Protein gp41, Peptide Fragments, 3. Good health, HIV-2/drug effects, Quaternary Ammonium Compounds, HIV-1/drug effects, Anti-HIV Agents/therapeutic use, CCR5 Receptor Antagonists, HIV-2, HIV-1, HIV Infections/virology, Female, Triazoles/therapeutic use

File Description: application/pdf

Access URL: http://repositorio.chlc.min-saude.pt/bitstream/10400.17/2417/1/Antiviral%20Therapy%202011.pdf
https://pubmed.ncbi.nlm.nih.gov/22293827
https://www.ncbi.nlm.nih.gov/pubmed/22293827
https://europepmc.org/abstract/MED/22293827
http://comum.rcaap.pt/bitstream/10400.26/4993/1/Borrego%20et%20al%20%20Antiviral%20Therapy%202011.pdf
http://www.intmedpress.com/journals/avt/abstract.cfm?id=1996&pid=48
https://repositorio.chlc.min-saude.pt/bitstream/10400.17/2417/1/Antiviral%20Therapy%202011.pdf
https://pubmed.ncbi.nlm.nih.gov/22293827/
https://hdl.handle.net/10400.26/4993
https://hdl.handle.net/10451/59111
http://hdl.handle.net/10400.17/2417

Subgroup Analyses of Maraviroc in Previously Treated R5 HIV-1 Infection

Authors: Fätkenheuer, Gerd Nelson, Mark Lazzarin, Adriano et al.

Contributors: Fätkenheuer, Gerd Nelson, Mark Lazzarin, Adriano et al.

Source: New England Journal of Medicine, Vol. 359, No 14 (2008) pp. 1442-1455

Subject Terms: Male, 0301 basic medicine, HIV Infections, Enfuvirtide, Immunologie & maladie infectieuse, HIV Envelope Protein gp41/therapeutic use, 0302 clinical medicine, Transaminases/blood, HIV Fusion Inhibitors, Odds Ratio, Ethnicity, Immunology & infectious disease, Human health sciences, ddc:616, HIV Infections/drug therapy/immunology/virology, Receptors, CCR5/antagonists & inhibitors/genetics, Middle Aged, Viral Load, Hepatitis B, Hepatitis C, HIV-1/chemistry/genetics, HIV Envelope Protein gp41, 3. Good health, Treatment Outcome, Anti-Retroviral Agents, HIV Fusion Inhibitors/adverse effects/therapeutic use, CCR5 Receptor Antagonists, Drug Therapy, Combination, Female, Cyclohexanes/adverse effects/therapeutic use, Adult, Genotype, Triazoles/adverse effects/therapeutic use, Ethnic Groups, Sciences de la santé humaine, 03 medical and health sciences, EMC MM-04-28-04, SDG 3 - Good Health and Well-being, Double-Blind Method, Cyclohexanes, Humans, RNA, Viral/blood, Aged, Hepatitis B/blood/complications, Peptide Fragments/therapeutic use, Anti-Retroviral Agents/adverse effects/therapeutic use, CD4 Lymphocyte Count, HIV-1, Hepatitis C/blood/complications

File Description: application/pdf

Access URL: https://pubmed.ncbi.nlm.nih.gov/18832245
https://pure.eur.nl/en/publications/02d81c5a-0d7c-4757-80b6-550ce7f47f74
https://archive-ouverte.unige.ch/unige:2103
https://orbi.uliege.be/handle/2268/16294
https://www.ncbi.nlm.nih.gov/pubmed/18832245
https://moh-it.pure.elsevier.com/en/publications/subgroup-analyses-of-maraviroc-in-previously-treated-r5-hiv-1-inf
https://europepmc.org/abstract/MED/18832245
https://www.nejm.org/doi/abs/10.1056/NEJMoa0803154
https://archive-ouverte.unige.ch/unige:2103
https://archive-ouverte.unige.ch/unige:2103
https://doi.org/10.1056/nejmoa0803154
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=000259631700005&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=0c7ff228ccbaaa74236f48834a34396a
https://doi.org/10.1056/NEJMoa0803154
https://hdl.handle.net/11573/84304

Suppressive Mechanism of Salmosin, a Novel Disintegrin in B16 Melanoma Cell Metastasis

Authors: In Cheol Kang Kwang Hoe Chung Doo Sik Kim et al.

Contributors: In Cheol Kang Kwang Hoe Chung Doo Sik Kim et al.

Source: Biochemical and Biophysical Research Communications. 275:169-173

Subject Terms: Experimental/drug therapy, 0301 basic medicine, Lung Neoplasms, Disintegrins, Melanoma, Experimental, Recombinant Proteins/chemistry, Inbred C57BL, Vitronectin/metabolism, Mice, Recombinant Proteins/therapeutic use, Antineoplastic Agents/chemistry, Receptors, Lung Neoplasms/pathology, Cell Adhesion/drug effects, Recombinant Proteins/pharmacology, Disintegrins/genetics, Melanoma, Disintegrins/pharmacology, Extracellular Matrix Proteins, Cultured, Histocytochemistry, Vitronectin/antagonists & inhibitors, Crotalid Venoms/therapeutic use, Tumor Cells, disintegrin, 3. Good health, Experimental/pathology, Drug Combinations, Collagen, Drug, Antineoplastic Agents/pharmacology, Oligopeptides, Cell Division, Peptide Fragments/chemistry, Cell Division/drug effects, Antineoplastic Agents, Extracellular Matrix Proteins/metabolism, Dose-Response Relationship, 03 medical and health sciences, Crotalid Venoms/pharmacology, Collagen/metabolism, Oligopeptides/analysis, Crotalid Venoms, Cell Adhesion, Crotalid Venoms/genetics, Animals, Neoplasm Invasiveness, Lung Neoplasms/secondary, Experimental/metabolism, Lung Neoplasms/drug therapy, Crotalid Venoms/chemistry, Disintegrins/therapeutic use, Peptide Fragments/therapeutic use, Peptide Fragments/pharmacology, Dose-Response Relationship, Drug, Antineoplastic Agents/therapeutic use, Proteoglycans/metabolism, Peptide Fragments, Laminin/metabolism, Mice, Inbred C57BL, salmosin, Laminin, Neoplasm Transplantation

Access URL: https://pubmed.ncbi.nlm.nih.gov/10944460
https://yonsei.pure.elsevier.com/en/publications/suppressive-mechanism-of-salmosin-a-novel-disintegrin-in-b16-mela
https://www.sciencedirect.com/science/article/pii/S0006291X00931309
https://www.cabdirect.org/cabdirect/abstract/20013143157
https://www.cabdirect.org/abstracts/20013143157.html
https://www.ncbi.nlm.nih.gov/pubmed/10944460
https://europepmc.org/abstract/MED/10944460

HIV entry inhibitors

Authors: Este, J. A. Telenti, A.

Subject Terms: Anti-HIV Agents/classification/*therapeutic use Clinical Trials HIV Envelope Protein gp41/*therapeutic use HIV Fusion Inhibitors/*therapeutic use HIV Infections/*prevention & control HIV-1/*physiology Heterocyclic Compounds/*therapeutic use Humans Peptide Fragments/*therapeutic use Receptors, CCR5/*antagonists & inhibitors Virus Replication/*drug effects

Relation: The Lancet; https://iris.unil.ch/handle/iris/51570; serval:BIB_1AC21802D15B; 000247862300033

Availability: https://iris.unil.ch/handle/iris/51570
https://doi.org/10.1016/S0140-6736(07)61052-6

Angiogenèse et cancer de vessie: marqueur tumoral à la mode ou nouvelle cible thérapeutique [Angiogenesis and bladder cancer: trendy prognostic factor or new therapeutic target?].

Authors: Jayet, C. Deperthes, D. Leisinger, H.J.

Subject Terms: Angiogenesis Inducing Agents/antagonists & inhibitors, Angiogenesis Inducing Agents/physiology, Angiogenesis Inhibitors/therapeutic use, Animals, Antineoplastic Agents/therapeutic use, Carcinoma, Transitional Cell/diagnosis, Transitional Cell/drug therapy, %22">Transitional Cell/ , Clinical Trials as Topic, Collagen/therapeutic use, Endostatins, Fibroblast Growth Factor 2/antagonists & inhibitors, Humans, Lymphatic Metastasis, Mice, Nude, Neoplasm Transplantation, Neovascularization, Pathologic/drug therapy, Peptide Fragments/therapeutic use, Phenotype, Prognosis, Rabbits, Research, Retrospective Studies, Risk Factors, Thrombospondin 1/physiology, Urinary Bladder Neoplasms/diagnosis, Urinary Bladder Neoplasms/drug therapy

Relation: Annales d'urologie; https://iris.unil.ch/handle/iris/176549; serval:BIB_7FE17BC09C02; 000176929900007

Availability: https://iris.unil.ch/handle/iris/176549
https://doi.org/10.1016/S0003-4401(02)00105-5